Literature DB >> 23380296

Late gadolinium enhancement in cardiac transplant patients is associated with adverse ventricular functional parameters and clinical outcomes.

Craig R Butler1, Andreas Kumar, Mustafa Toma, Richard Thompson, Kelvin Chow, Debra Isaac, Daniel Kim, Mark Haykowsky, Matthias G Friedrich, Ian Paterson.   

Abstract

BACKGROUND: Heart transplant recipients (HTRs) experience multiple cardiac complications, many of which might produce myocardial fibrosis. Cardiovascular magnetic resonance imaging (CMR) can image myocardial fibrosis using late gadolinium enhancement (LGE) imaging. We hypothesized that the presence and volume of LGE in heart transplant recipients correlates with left ventricular (LV) functional parameters and clinical outcomes.
METHODS: Thirty-eight stable HTRs underwent a CMR study and clinical follow-up.
RESULTS: In 38 stable HTRs, LGE was seen in 19 patients (50%), of which 15 (79%) had a nonischemic pattern and 4 (21%) had an ischemic pattern. LGE volume was associated with reduced LV ejection fraction (EF) (R(2) = 0.57; P = 0.001) and increased LV end-diastolic volume (R(2) = 0.59; P = 0.001). The presence of LGE was associated with cardiovascular death or hospitalization within the next year (P = 0.04), and patients who died or were hospitalized had more LGE than those that were not hospitalized (15 g vs 7 g; P = 0.03).
CONCLUSIONS: LGE is common in HTR and is associated with adverse ventricular remodelling and adverse clinical outcomes. LGE might be a useful noninvasive approach to monitor graft disease in asymptomatic patients after heart transplant.
Copyright © 2013 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23380296     DOI: 10.1016/j.cjca.2012.10.021

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  8 in total

1.  Myocardial Fibrosis and Prognosis in Heart Transplant Recipients.

Authors:  Andrew Hughes; Osama Okasha; Afshin Farzaneh-Far; Felipe Kazmirczak; Prabhjot S Nijjar; Pratik Velangi; Mehmet Akçakaya; Cindy M Martin; Chetan Shenoy
Journal:  Circ Cardiovasc Imaging       Date:  2019-10-15       Impact factor: 7.792

2.  Consequences of Retained Defibrillator and Pacemaker Leads After Heart Transplantation-An Underrecognized Problem.

Authors:  Luise Holzhauser; Teruhiko Imamura; Hemal M Nayak; Nitasha Sarswat; Gene Kim; Jayant Raikhelkar; Sara Kalantari; Amit Patel; David Onsager; Tae Song; Takeyoshi Ota; Valluvan Jeevanandam; Gabriel Sayer; Nir Uriel
Journal:  J Card Fail       Date:  2018-01-08       Impact factor: 5.712

3.  Natural History of Myocardial Late Gadolinium Enhancement Predicts Adverse Clinical Events in Heart Transplant Recipients.

Authors:  Kongkiat Chaikriangkrai; Muhannad Aboud Abbasi; Roberto Sarnari; Daniel Lee; Allen S Anderson; Kambiz Ghafourian; Sadiya S Khan; Esther E Vorovich; Jonathan D Rich; Jane E Wilcox; Julie A Blaisdell; Clyde W Yancy; James Carr; Michael Markl
Journal:  JACC Cardiovasc Imaging       Date:  2019-07-17

Review 4.  Multi-modal imaging of the pediatric heart transplant recipient.

Authors:  Jonathan H Soslow; Margaret M Samyn
Journal:  Transl Pediatr       Date:  2019-10

Review 5.  The Value of Cardiovascular Magnetic Resonance in Heart Transplant Patients.

Authors:  Anna B Reid; Nick Waldron; Matthias Schmitt; Christopher A Miller
Journal:  Curr Cardiol Rep       Date:  2015-07       Impact factor: 2.931

6.  Diagnostic performance of late gadolinium enhancement in the assessment of acute cellular rejection after heart transplantation.

Authors:  Evrim Şimşek; Sanem Nalbantgil; Naim Ceylan; Mehdi Zoghi; Hatice Soner Kemal; Çağatay Engin; Tahir Yağdı; Mustafa Özbaran
Journal:  Anatol J Cardiol       Date:  2015-06-18       Impact factor: 1.596

7.  Histological validation of cardiovascular magnetic resonance T1 mapping markers of myocardial fibrosis in paediatric heart transplant recipients.

Authors:  Seiko Ide; Eugenie Riesenkampff; David A Chiasson; Anne I Dipchand; Paul F Kantor; Rajiv R Chaturvedi; Shi-Joon Yoo; Lars Grosse-Wortmann
Journal:  J Cardiovasc Magn Reson       Date:  2017-02-01       Impact factor: 5.364

8.  Prognostic Value of Myocardial Extracellular Volume Fraction and T2-mapping in Heart Transplant Patients.

Authors:  Kongkiat Chaikriangkrai; Muhannad Aboud Abbasi; Roberto Sarnari; Ryan Dolan; Daniel Lee; Allen S Anderson; Kambiz Ghafourian; Sadiya S Khan; Esther E Vorovich; Jonathan D Rich; Jane E Wilcox; Julie A Blaisdell; Clyde W Yancy; James Carr; Michael Markl
Journal:  JACC Cardiovasc Imaging       Date:  2020-03-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.